scholarly journals Primary Hyperaldosteronism: A Rare Cause of Malignant Hypertension with Thrombotic Microangiopathy in a Kidney Transplant Recipient

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Carolina Ormonde ◽  
Sara Querido ◽  
Nuno Rombo ◽  
Rita Roque ◽  
Belarmino Clemente ◽  
...  

Thrombotic microangiopathy (TMA) is a rare disease that presents with haemolysis and organ damage. The kidney is one of the main affected organs, and TMA is associated with serious complications and increased mortality. In transplanted patients, TMA is even less common and has a variety of possible causes, including thrombotic thrombocytopenic purpura (TTP) and haemolytic-uremic syndrome (HUS), infections, drugs, autoimmune disease, tumours, and malignant hypertension. Transplant-related causes, such as antibody-mediated rejection, calcineurin inhibitors, and viral infections, need to be considered as well. The authors report a rare case of TMA in a kidney transplant recipient, whose investigation revealed malignant hypertension secondary to primary hyperaldosteronism.

2020 ◽  
pp. 1-4
Author(s):  
Muhammad A. Bukhari ◽  
Abdulaziz Al-Thumali ◽  
El-Sadig Yousif ◽  
Muhammad A. Bukhari ◽  
Najla K Almalki ◽  
...  

Thrombotic microangiopathy (TMA) is an uncommon, life-threatening complication that adversely affects kidney transplant recipient and allograft survival. Post-transplantation TMA can occur as recurrence of the primary TMA or as a de novo condition. The latter can be triggered by numerous factors post-transplantation including calcineurin inhibitors, certain infections and antibody-mediated rejection. Rejection-associated TMAs carry a significantly lower graft survival rate compared with post-transplant TMAs that are not associated with rejection. In this case report, we present a rare case of rejection-associated TMA in a recently transplanted renal allograft that was managed in Al-Hada Armed Forces Hospital. Despite the poor expected outcome of this condition; the patient was successfully treated after early initiation of medical interventions. Transplantation teams may face many challenges managing such a combination of medical conditions, which may halt pursuing appropriate diagnostic and therapeutic measures in a timely fashion. This article highlights some of these challenges for better understanding of such a complex condition.


2015 ◽  
Vol 9 (4) ◽  
pp. 155-158
Author(s):  
Cengiz Bulut ◽  
Ebru Gok Oguz ◽  
Basol Canbakan ◽  
Deniz Ayli

Nephrology ◽  
2018 ◽  
Vol 23 ◽  
pp. 81-84
Author(s):  
Makoto Sagasaki ◽  
Yasuyuki Nakada ◽  
Izumi Yamamoto ◽  
Mayuko Kawabe ◽  
Takafumi Yamakawa ◽  
...  

Nephrology ◽  
2016 ◽  
Vol 21 ◽  
pp. 41-43 ◽  
Author(s):  
Hiroyuki Shirai ◽  
Jun Yashima ◽  
Tamotsu Tojimbara ◽  
Kazuho Honda

2020 ◽  
Vol 24 (5) ◽  
Author(s):  
Vasiliki Karava ◽  
Hara Gakiopoulou ◽  
Argyroula Zampetoglou ◽  
Smaragdi Marinaki ◽  
Sofia Havaki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document